Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
140 hedge funds and large institutions have $372M invested in Flexion Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 36 reducing their positions, and 24 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
69% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 36
3% less funds holding
Funds holding: 145 → 140 (-5)
12% less capital invested
Capital invested by funds: $421M → $372M (-$49.2M)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
61% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $2.64M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$10.7M |
| 2 |
CC
Clearline Capital
New York
|
+$6.13M |
| 3 |
O
OrbiMed
New York
|
+$3.92M |
| 4 |
Morgan Stanley
New York
|
+$3.35M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$36.7M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.68M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.82M |
| 4 |
Two Sigma Investments
New York
|
-$3.54M |
| 5 |
VVM
Versant Venture Management
San Francisco,
California
|
-$2.64M |
FLXN Hedge Fund Activity: Q2 2021 in Review
140 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2021, worth a combined $372M — down 12% from $421M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of FLXN and 19 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 61 added.
The largest buyer was State Street, adding an estimated $10.7M. The largest seller was Miller Value Partners, exiting entirely with an estimated $36.7M sold.
- 140 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2021, down from 145 in Q1 2021.
- Funds reported $372M of Flexion Therapeutics, Inc. stock for Q2 2021, down 12% quarter-over-quarter.
- 19 funds opened new Flexion Therapeutics, Inc. positions in Q2 2021 and 24 closed out, a net change of -5 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2021 was State Street, an estimated $10.7M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2021 was Miller Value Partners, an estimated $36.7M sold.
Based on aggregated 13F filings for Q2 2021.